TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
This summer, our team at Venus Concept Ltd. is celebrating another huge company milestone: the closing of a $38 million equity investment, announced on July 13, 2017.
The investment goes a long way to support the rapid growth of our unique subscription-based service model, the first and only of its kind in the aesthetic technology industry. We have expanded our subscription platform by serving the top treatment providers and practices across the world, selling devices in over 60 countries—including 27 with direct offices. We’re excited to put this new round of financing to work in developing incredible aesthetic technology.
We are proud to offer best-in-class devices with unmatched marketing support and the most comprehensive warranty program in the industry. Our devices are designed in cost-effective and proprietary ways, enabling us to grow beyond the aesthetic industry's traditional dermatology and plastic surgery market, and into non-traditional spaces.
That means that you can find practitioners operating and loving Venus Concept devices in family and general practices, internal medicine, obstetrics and gynecology, and medical spas. Approximately 70 percent of our devices are sold in non-traditional markets, and our clients rely on our devices for the most highly-demanded treatments with exceptional patient satisfaction. We’re happy to announce that we have the support of these financing partners to continue working with such a uniquely accessible and successful model.
This equity investment was led by EW Healthcare Partners, along with significant participation from HealthQuest Capital, and Madryn Asset Management.
EW Healthcare Partners is a well-established growth equity firm, working with innovative players in the world of pharmaceuticals, healthcare technology, and medical devices. In the words of Scott Barry, Managing Director of EW Healthcare Partners, this investment is an exciting opportunity to participate in building something extraordinary.
“We are pleased to be supporting [Venus Concept CEO Dom Serafino] and the management team of Venus Concept as they continue to successfully expand their product portfolio and services globally,” said Mr. Barry. “We believe that their differentiated subscription model and unique products positions them well to take full advantage of tailwinds in the non-invasive aesthetic market. We are excited to participate in the growth of the company.”
HealthQuest Capital and Madryn Asset Management are the other key firms involved in this round of equity financing. HealthQuest Capital is known for its dedication to early growth investment in companies that put patient experience at the forefront of healthcare technology with a track record of economic success. And as leading-edge investors in healthcare innovation, Madryn Asset Management pairs their financing support with a history of high-value returns and exceptional industry expertise.
For more information call: (888) 907-0115 // info@venusconcept.com // 235 Yorkland Blvd., Suite 900, Toronto, ON, M2J 4Y8 Canada
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction.
Venus Versa™ is licensed by Health Canada as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are licensed by Health Canada for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are licensed by Health Canada for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is licensed by Health Canada for the treatment of acne vulgaris. The DiamondPolar™ applicator is licensed by Health Canada for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is licensed by Health Canada for dermatological procedures requiring ablation and resurfacing of the skin.
NeoGraft® is licensed by Health Canada with indication for use in suction-assisted follicular extraction and re-implantation. It is an auto-graft system and can be used on both male and female patients.
ARTAS iX™ is licensed by Health Canada with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
Venus Legacy™ is licensed by Health Canada for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Velocity™ is licensed by Health Canada for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
The Venus Viva™ is licensed by Health Canada as a non-invasive medical aesthetic device, intended for use in dermatologic and general surgical procedures requiring ablation and resurfacing of the skin, using the Viva™/Viva™ MD applicator, and reduction in the appearance of wrinkle and rhytides in Fitzpatrick skin types I - IV using the DiamondPolar™ applicator.
Venus Epileve™ is licensed by Health Canada for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Freeze Plus™ is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of cellulite on the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators.
Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction.
Venus Glow™ provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Skin™ is a skin care line of various lotions and creams intended to improve different aspects of skin appearance, skin serums, and skin nourishment solutions.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More